# Depo-Medrol on Psoas After LLIF

> **NCT05929755** · PHASE4 · RECRUITING · sponsor: **Hardeep Singh** · enrollment: 80 (estimated)

## Conditions studied

- Muscle Weakness
- Pain, Postoperative
- Paresthesia
- Pain, Muscle

## Interventions

- **DRUG:** Depo-Medrol
- **DRUG:** Gel-Flow NT

## Key facts

- **NCT ID:** NCT05929755
- **Lead sponsor:** Hardeep Singh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-12
- **Primary completion:** 2025-08
- **Final completion:** 2027-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05929755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05929755, "Depo-Medrol on Psoas After LLIF". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05929755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*